Amgen (AMGN) SVP Rachna Khosla Sells $1.35M of Stock
Published on · Source: investing.com

AI Summary
Summarized by AI from the source belowRachna Khosla, Senior Vice President at Amgen (AMGN), sold $1.35 million worth of the company’s stock. This sale highlights individual stock transactions by executives, which can indicate their confidence or outlook on their company's performance. While insider sales like this don’t always predict declines, they can reflect an executive's personal financial moves. Monitoring such transactions is important for ordinary investors as they can be signals of future company performance.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Amgen Inc. (AMGN)
Amgen is one of the world’s largest biotechnology companies.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier AMGN news
- Amgen (AMGN) SVP Sells $1.56M in Stock after Option Exercise
- Amgen (AMGN) SVP Nancy Grygiel Disposes $1.19M in Stock
- Pfizer (PFE) Trades at 8x Earnings, Seagen Integration Drives Growth
- Amgen (AMGN) Linked to 20 Deaths in Japan from Drug Usage
- Amgen (AMGN) Stock Drops After Kissei's Tavneos Liver Risk Warning
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.



